PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91018F00003Eo14042 TASK ORDER TITLE: preclinical efficacy — Iit Research Institute

Iit Research Institute holds $11.5M across 33 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Jul 30, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Nih Nci

Awarding office

Iit Research Institute

Recipient

Jul 30, 2026

PoP end

$-187,432.68

Obligated

541711

NAICS

AN11

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Iit Research Institute — $90

Contract facts

Federal

Contract number75N91018F00003

Also listed asHHSN261201500042I-75N91018F00003

AgencyNih Nci

Awarding officeNih Nci

IncumbentIit Research Institute

UEIDGBUFQYMKWB5

NAICS541711

No full NAICS 541711 intel page yet. Browse NAICS intelligence

PSCAN11

Parent IDIQ / IDVHHSN261201500042I

Place of performanceCHICAGO, IL

Related solicitationNO1CN500347

PoP end (current)Jul 30, 2026

Obligated$-187,432.68

EO14042 TASK ORDER TITLE: PRECLINICAL EFFICACY EVALUATION OF THE LIPID - BASED SMEDDS FORMULATION OF DIM, BR-9001 is a federal award for Nih Nci held by Iit Research Institute. Estimated value $32.8M ($-187,432.68 obligated). Current period of performance ends Jul 30, 2026. Last award drew 1 bidder. Place of performance: CHICAGO, IL. Related solicitation NO1CN500347.

EO14042 TASK ORDER TITLE: PRECLINICAL EFFICACY EVALUATION OF THE LIPID - BASED SMEDDS FORMULATION OF DIM, BR-9001

Recompete timing

Public

● Past PoP end (21 days ago)

Current PoP ended Jul 30, 2026 (21 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Iit Research Institute — $11.5M obligated across 33 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$11.5M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N91018F00003?

75N91018F00003 (Eo14042 TASK ORDER TITLE: preclinical efficacy) is a Nih Nci award with an estimated value of $32.8M, currently held by Iit Research Institute. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91018F00003?

Nih Nci awarded 75N91018F00003 to Iit Research Institute.

Who is the incumbent on 75N91018F00003?

Iit Research Institute is the incumbent with $11.5M across 33 related awards in SCOUT’s public footprint. The current period of performance ends Jul 30, 2026.

When does Iit Research Institute’s 75N91018F00003 come up for recompete?

SCOUT tracks a period-of-performance end of Jul 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action May 29, 2026